Form 4: PetVivo Holdings CFO Receives and Vests Restricted Stock Units as Compensation
SEC Form 4
Garry N. Lowenthal, CFO of PetVivo Holdings, Inc., received and vested 180,000 shares of common stock as compensation for past performance.
Summary
- On September 17, 2024, Garry N. Lowenthal, the Chief Financial Officer of PetVivo Holdings, Inc., received 90,000 shares of common stock.
- These shares were granted as restricted stock units and vested immediately on the grant date as partial compensation for past performance.
- Additionally, 90,000 restricted stock units previously granted in April 2024 also vested on September 17, 2024, due to an amendment by the Issuer's Compensation Committee.
- The total number of shares beneficially owned by Lowenthal after these transactions is 180,000.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of executive compensation. The vesting of stock units is generally a positive sign of alignment, but it doesn't necessarily indicate strong positive or negative sentiment.
Positives
- The grant and vesting of restricted stock units to the CFO could be seen as a positive sign of the company's recognition of his contributions.
- The vesting of these shares aligns the CFO's interests with those of the shareholders.
Industry Context
This type of equity compensation is common for executives in publicly traded companies to align their interests with shareholders and incentivize performance.
Comparison to Industry Standards
- Equity compensation for CFOs varies widely based on company size, industry, and performance.
- Comparing Lowenthal's compensation to CFOs at similar-sized companies in the animal health or biotechnology sectors would provide a more detailed benchmark.
- Companies like Zoetis or Elanco Animal Health, while much larger, offer a glimpse into the types of equity compensation packages offered in the broader animal health industry.
Stakeholder Impact
- Shareholders may view the equity compensation as a way to incentivize the CFO to improve company performance.
- Employees may see this as a positive sign of the company's financial health and commitment to its leadership.
Key Dates
| Date | Description |
|---|---|
| April 2024 | 90,000 restricted stock units were previously granted to the Reporting Person. |
| 09/17/2024 | Date of transaction: Grant and vesting of 90,000 restricted stock units and vesting of previously granted 90,000 restricted stock units. |
| 09/19/2024 | Date of signature on the Form 4. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.